Lifeboat Foundation

Volunteers will be injected with red blood cells grown from stem cells in the lab. If it works it could mean blood donors are no longer required.

We looked into whether these for-profit clinics will really help you.

CRISPR looks set to be the future of gene editing. But experts are cautioning that this revolutionary technique needs to be developed carefully. So what do the next few years hold?

Merry Christmas

Is the Fountain of Youth still just a dream, or does hope spring eternal when it comes to beating the curse of aging? Having haunted us for centuries, is a solution finally within our grasp? We spoke to Dr Aubrey de Grey, anti-aging pioneer, chief science officer, and co-founder of SENS Research Foundation.

Follow @SophieCo_RT

Continue reading “There will be no old people – anti-aging SophieCo” »

Companies use different algorithms based on different sets of data. Most of that data comes from people of recent European ancestry.

The problem, obviously, is that a lot of people don’t have grandparents or great-great-great-grandparents from England or Italy or Denmark. Most people on Earth, actually! That means if you’re from, say, Asia or Africa, you might not get as detailed a profile as you’d like.

My mother, who was born in the Philippines, actually got an update from 23andMe with new information about her heritage. Her history didn’t change. But as the company gets more DNA kits from people of Asian descent, the algorithm churns out modified results. Which is great … but that does mean right now, if you’re not white, you might have to wait a bit longer for more accurate results.

New program coming on-line at Bioquark Inc. (www.bioquark.com) — Ectocrine interactions (the“Ectocrinome”) represents a completely unexplored area related to human health

https://www.prweb.com/releases/bioquark_inc_and_ectocrine_te…004155.htm

Building on several years of research into a protein responsible for leukemia, a newly published paper has revealed success in slowing the progression of the deadly cancer in mouse models. The researchers suggest two new prospective therapies can now be combined into one “super drug” and progress into human clinical trials.

It’s one of the fundamental forces, and we rely heavily on them. They can do some damage too…

By coating nanoparticles with gold, researchers have successfully destroyed prostate cancer cells in people without damaging surrounding tissue.